American Century Companies Inc. Buys 39,185 Shares of HealthEquity, Inc. (NASDAQ:HQY)

American Century Companies Inc. lifted its position in HealthEquity, Inc. (NASDAQ:HQY) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 570,952 shares of the company’s stock after buying an additional 39,185 shares during the period. American Century Companies Inc. owned approximately 0.66% of HealthEquity worth $54,783,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its position in HealthEquity by 1.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock worth $86,909,000 after purchasing an additional 14,532 shares during the last quarter. Raymond James Trust N.A. boosted its holdings in shares of HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after buying an additional 132 shares during the last quarter. Citigroup Inc. grew its position in HealthEquity by 73.0% during the third quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock valued at $8,357,000 after buying an additional 43,084 shares during the period. Cerity Partners LLC increased its holdings in HealthEquity by 15.1% during the third quarter. Cerity Partners LLC now owns 17,259 shares of the company’s stock valued at $1,413,000 after buying an additional 2,258 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its position in HealthEquity by 165.7% in the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock worth $1,673,000 after acquiring an additional 12,745 shares during the period. Institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.20% of the stock is currently owned by insiders.

HealthEquity Price Performance

HQY stock opened at $89.22 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company’s fifty day moving average price is $104.17 and its 200-day moving average price is $95.89. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a market capitalization of $7.72 billion, a PE ratio of 81.85, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on HQY shares. Wells Fargo & Company boosted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Finally, Barrington Research restated an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $113.31.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.